On March 5, AFTD hosted a virtual Externally Led Patient-Focused Drug Development (EL-PFDD) meeting focused on FTD.  This meeting was designed to give all whose lives have been affected by FTD the chance to share their direct experience with representatives from the U.S. Food and Drug Administration (FDA).

We’re grateful to all who chose to be part of this event. People and families affected by FTD are encouraged to share post-meeting comments via our EL-PFDD landing page. Stay tuned: A video archive of our meeting will be available soon.